CFAR Social and Behavioral Sciences Research Network (SBSRN) 1 st Scientific Meeting Summary Philadelphia, PA October 10 -13, 2006 SBSRN Executive Committee

CFAR Social and Behavioral Sciences Research Network (SBSRN)

1st Scientific Meeting Summary

Philadelphia, PA October 10 -13, 2006

CFAR Social and Behavioral Sciences Research Network (SBSRN)

1st Scientific Meeting Summary

Philadelphia, PA October 10 -13, 2006

SBSRN Executive CommitteeSBSRN Executive Committee

Social and Behavioral SciencesResearch Network

CFAR

SBSRN Executive CommitteeSBSRN Executive Committee

CFAR RepresentationCFAR Representation● Albert Einstein College of

Medicine/Montefiore Medical Center

● Baylor College of Medicine/University of Texas

● Brown University/Tufts University/Lifespan

● Case Western Reserve University/University Hospitals of Cleveland

● Duke University

● Emory University

● Harvard University Medical School

● John Hopkins University

● New York University College of Medicine

● Albert Einstein College of Medicine/Montefiore Medical Center

● Baylor College of Medicine/University of Texas

● Brown University/Tufts University/Lifespan

● Case Western Reserve University/University Hospitals of Cleveland

● Duke University


● Harvard University Medical School

● John Hopkins University

● New York University College of Medicine

● University of Alabama at Birmingham

● University of California, Los Angeles

● University of California, San Francisco

● University of Colorado

● University of Massachusetts Medical Center

● University of North Carolina, Chapel Hill

● University of Pennsylvania

● University of Washington


● University of California, Los Angeles

● University of California, San Francisco

● University of Colorado

● University of Massachusetts Medical Center

● University of North Carolina, Chapel Hill


● University of WashingtonSocial and Behavioral Sciences

Research NetworkCFAR

Other Institutions RepresentedOther Institutions Represented

● CDC

● NIAID

● NICHD

● NIMH

● OAR

● NIDA

● HVTN

● Philadelphia Department of Public Health

● CDC

● NIAID

● NICHD

● NIMH

● OAR

● NIDA

● HVTN

● Philadelphia Department of Public Health

● Center for AIDS Intervention Research (CAIR)- Medical College of Wisconsin

● Yale University

● Temple University

● Rutgers University

● SUNY- Downstate

● amfAR

● Pangaea

● Center for AIDS Intervention Research (CAIR)- Medical College of Wisconsin

● Yale University

● Temple University

● Rutgers University

● SUNY- Downstate

● amfAR

● Pangaea


CFAR

Conference AttendeesConference Attendees● 120 Attendees

● 17 CFARs represented

● 14 other institutions represented

Characteristics of Attendees

● 65 (54 %) PhD

● 1 (.008%) PsyD

● 1 (.008%) ScD

● 16 (13%) MD

● 12 (10%) MPH

● 3 (.02 %) RN/MSN

● 3 (0.2%) MSW/LCSW

● 9 (7%) Students

● 20 (17%) Unknown degree status

● 120 Attendees


● 14 other institutions represented


● 65 (54 %) PhD

● 1 (.008%) PsyD

● 1 (.008%) ScD

● 16 (13%) MD

● 12 (10%) MPH

● 3 (.02 %) RN/MSN

● 3 (0.2%) MSW/LCSW

● 9 (7%) Students

● 20 (17%) Unknown degree statusSocial and Behavioral Sciences


Mentoring Day Participating CFARs Mentoring Day Participating CFARs


● Harvard University

● Brown University




● Harvard University

● Brown University



● Montefiore Medical Center● University of Colorado ● Duke University● University of Washington● SUNY Downstate*

● Montefiore Medical Center● University of Colorado ● Duke University● University of Washington● SUNY Downstate*

* Not a CFARSocial and Behavioral Sciences


Mentoring Day Participants Mentoring Day Participants ● 16 Mentees


● 1 other institution represented


● 9 (56%) PhD

● 4 (25%) MD

● 3 (19%) MPH

● 1 (.06%) DrPH

● 1 (.06%) PsyD

● 1 (.06%) MS

● 1 (.06%) MSN/NP

● 1 (0.6%) LCSW

● 16 Mentees


● 1 other institution represented


● 9 (56%) PhD

● 4 (25%) MD

● 3 (19%) MPH

● 1 (.06%) DrPH

● 1 (.06%) PsyD

● 1 (.06%) MS

● 1 (.06%) MSN/NP

● 1 (0.6%) LCSW Social and Behavioral SciencesResearch Network

CFAR

● 5 (31 %) Males ● 11 (69%) Females● 6 (38%) Ethnic/Racial

minorities

● 5 (31 %) Males ● 11 (69%) Females● 6 (38%) Ethnic/Racial

minorities

Early Career and Transitional Investigators Mentoring DayOctober 10, 2006



CFAR

Mentoring Day Goals● to provide a team mentoring, supportive and collegial atmosphere where early career

and transitional SBS investigators can meet and discuss common challenges they confront in establishing interdisciplinary HIV research careers

● to assist in addressing this gap by identifying promising early career and transitional investigators from CFARs around the country, providing a daylong orientation and facilitating early career and transitional investigator linkages with senior CFAR scientists

● to expose early career and transitional investigators to a variety of seminars specifically tailored to their needs: these seminars include: crafting a successful NIH grant; mechanisms for support for early career and transitional investigators; HIV research priorities; and a brief review of HIV prevention research among (a) adolescents, (b) substance users, (c) mental health aspects of HIV, (d) women, and (e) international HIV prevention research

● to provide the opportunity to meet with senior-level researchers, and prosper from their experiences; both successes and failures

Mentoring Day Goals● to provide a team mentoring, supportive and collegial atmosphere where early career

and transitional SBS investigators can meet and discuss common challenges they confront in establishing interdisciplinary HIV research careers

● to assist in addressing this gap by identifying promising early career and transitional investigators from CFARs around the country, providing a daylong orientation and facilitating early career and transitional investigator linkages with senior CFAR scientists

● to expose early career and transitional investigators to a variety of seminars specifically tailored to their needs: these seminars include: crafting a successful NIH grant; mechanisms for support for early career and transitional investigators; HIV research priorities; and a brief review of HIV prevention research among (a) adolescents, (b) substance users, (c) mental health aspects of HIV, (d) women, and (e) international HIV prevention research

● to provide the opportunity to meet with senior-level researchers, and prosper from their experiences; both successes and failures




CFAR




CFAR

● The perspective from what really happens at a review session and how to write for the reader. I have been to many grant writing seminars and this was the most helpful for understanding our role in writing for the entire process.

● Individualized attention

● Tips on grant writing; multiple voices and perspectives; clarity

● Opportunity to network and connect with other early investigators. The video on the grant evaluation process was useful

● The perspective from what really happens at a review session and how to write for the reader. I have been to many grant writing seminars and this was the most helpful for understanding our role in writing for the entire process.

● Individualized attention

● Tips on grant writing; multiple voices and perspectives; clarity

● Opportunity to network and connect with other early investigators. The video on the grant evaluation process was useful

What Participants Liked Most About Mentoring DayWhat Participants Liked Most About Mentoring Day

Mentoring Day Comments Mentoring Day Comments

● I wanted to give you a heart felt thanks for organizing and carrying out the mentoring day last week. I got a lot out of it, from the presentation on writing NIH grants, to our break out discussion, to meeting so many people. I imagine that it took a lot of effort to make the day happen, and I wanted to let you know that it was a very successful experience for me. I even came up with a new K award idea!

Again, many thanks, Rae Jean

● I wanted to give you a heart felt thanks for organizing and carrying out the mentoring day last week. I got a lot out of it, from the presentation on writing NIH grants, to our break out discussion, to meeting so many people. I imagine that it took a lot of effort to make the day happen, and I wanted to let you know that it was a very successful experience for me. I even came up with a new K award idea!

Again, many thanks, Rae Jean


CFAR

Mentoring Day CommentsMentoring Day Comments

● I found the meeting stimulating and was glad to have met so many folks with whom I share interests/goals. I know that it is extremely tough to carve out a 2-day period to accomplish a great deal of work, but felt that our working group was able to get a good start and make some connections with one another. You all did a beautiful job of pulling things together.

Thank you again,Cynthia

● I found the meeting stimulating and was glad to have met so many folks with whom I share interests/goals. I know that it is extremely tough to carve out a 2-day period to accomplish a great deal of work, but felt that our working group was able to get a good start and make some connections with one another. You all did a beautiful job of pulling things together.

Thank you again,Cynthia


CFAR

SBSRN Scientific SessionsOctober 11th – 12th

SBSRN Scientific SessionsOctober 11th – 12th

● Global Perspective of the HIV Pandemic - Chris Beyrer, MD, MPH (Director, Johns Hopkins Fogarty AITRP

● Cost Effectiveness Trials in HIV Prevention Studies - Stephen Pinkerton, PhD, Center for AIDS Intervention Research (CAIR), Medical College of Wisconsin)

● Factors Impacting on HIV Prevention and Treatment Effectiveness - James Walkup, PhD (Associate Professor, Institute for Health, Health Care Policy and Aging Research, Rutgers University)

● Examining and Reducing HIV Disparities in Race, Class, Gender, and Age - Sevgi Aral, PhD, MSc, MA (Associate Director for Science, Division of STD Prevention at the Centers for Disease Control and Prevention)

● Looking Toward the Future: Strategies to Identify and Intervene with Persons at Greatest Risk of HIV Infections - Thomas Coates, PhD (Professor, Division of Infectious Diseases, Prevention and Policy Research at the UCLA David Geffen School of Medicine; Core Scientist, CHIPTS)

● Defining, Designing, Implementing and Evaluating Effectiveness Trials for Vulnerable Populations - Jeffrey Kelly, PhD (Director, CAIR, Medical College of Wisconsin)

● Global Perspective of the HIV Pandemic - Chris Beyrer, MD, MPH (Director, Johns Hopkins Fogarty AITRP

● Cost Effectiveness Trials in HIV Prevention Studies - Stephen Pinkerton, PhD, Center for AIDS Intervention Research (CAIR), Medical College of Wisconsin)

● Factors Impacting on HIV Prevention and Treatment Effectiveness - James Walkup, PhD (Associate Professor, Institute for Health, Health Care Policy and Aging Research, Rutgers University)

● Examining and Reducing HIV Disparities in Race, Class, Gender, and Age - Sevgi Aral, PhD, MSc, MA (Associate Director for Science, Division of STD Prevention at the Centers for Disease Control and Prevention)

● Looking Toward the Future: Strategies to Identify and Intervene with Persons at Greatest Risk of HIV Infections - Thomas Coates, PhD (Professor, Division of Infectious Diseases, Prevention and Policy Research at the UCLA David Geffen School of Medicine; Core Scientist, CHIPTS)

● Defining, Designing, Implementing and Evaluating Effectiveness Trials for Vulnerable Populations - Jeffrey Kelly, PhD (Director, CAIR, Medical College of Wisconsin)


CFAR

SBSRN Scientific Topics (continued)SBSRN Scientific Topics (continued)● Community Involvement in HIV Research - Steve Wakefield (Director,

HVTN Legacy Project; HIV Vaccine Trials Network; Hutchinson Cancer Research Center)

● Government and Foundations: Funding Priorities and Strategies for Cross- CFAR Integrated ResearchNIH representatives● Christopher Gordon, PhD (Chief, Secondary HIV Prevention & Treatment

Adherence; Div of Mental Disorders, Behavioral Research & AIDS; NIMH)● David Burns, MD, MPH (DAIDS, Prevention Sciences Branch; NIAID)● William Grace, PhD (Behavioral and Social Science Research, OAR)● Susan Newcomer, PhD (Demographic & Behavioral Science Branch,

NICHD)● Richard Jenkins, PhD (Health Scientist Administrator, Prevention Research

Branch, NIDA)

Foundations● Rowena Johnston, PhD (Acting Director, Public Policy; AmfAR ● Eric Goosby, MD (Chief Executive Officer & Chief Medical Officer,

Pangaea Global AIDS Foundation)

● Community Involvement in HIV Research - Steve Wakefield (Director, HVTN Legacy Project; HIV Vaccine Trials Network; Hutchinson Cancer Research Center)

● Government and Foundations: Funding Priorities and Strategies for Cross- CFAR Integrated ResearchNIH representatives● Christopher Gordon, PhD (Chief, Secondary HIV Prevention & Treatment

Adherence; Div of Mental Disorders, Behavioral Research & AIDS; NIMH)● David Burns, MD, MPH (DAIDS, Prevention Sciences Branch; NIAID)● William Grace, PhD (Behavioral and Social Science Research, OAR)● Susan Newcomer, PhD (Demographic & Behavioral Science Branch,

NICHD)● Richard Jenkins, PhD (Health Scientist Administrator, Prevention Research

Branch, NIDA)

Foundations● Rowena Johnston, PhD (Acting Director, Public Policy; AmfAR ● Eric Goosby, MD (Chief Executive Officer & Chief Medical Officer,

Pangaea Global AIDS Foundation)


CFAR

Conference Participants Conference Participants

More Conference Participants… More Conference Participants…


CFAR

Scientific SpeakersScientific Speakers

Eric Goosby, Pangaea

Thomas Coates, UCLA

Steve Wakefield, HVTN


CFAR

Jeff Kelly, CAIR

NIH RepresentativesNIH Representatives

Chris Gordon, NIMH Susan Newcomer, NICHD William Grace, OAR

David Burns, NIAID Richard Jenkins, NIDASocial and Behavioral Sciences


A. Deliver the information clearly?Poor1.7%

Fair12.5%

Excellent55.8%

Good30.0%

B. Appear knowledgeable about the information?

Excellent71.7%

Good24.2%

Poor0.8%

Fair3.3%

N = 120


CFAR

Scientific Speaker EvaluationsScientific Speaker EvaluationsDid the speakers… Did the speakers…

E + G = 85.8 %

E + G = 95.9%

Excellent48.7%

Good41.2%

Fair6.0%

Speaker Evaluations (continued)Speaker Evaluations (continued)

Excellent48.7%

Good41.2%

Poor1.7%

Fair8.4%


CFAR

C. Make the information meaningful to your professional life?

D. Provide opportunities for discussion?

N = 119

N = 117

Did the speakers… Did the speakers…

E + G = 89.9 %

E + G = 94.0 %


CFAR

Good32.5%

Excellent56.6%

Poor4.2%

Fair6.7%

E. Deliver the information in a way for you to understand?

N = 120

Speaker Evaluations (continued)Speaker Evaluations (continued)

Did the speakers… Did the speakers…

E + G = 89.1 %

Good35.8%

Excellent54.2%

Poor1.7%

Fair8.3%

2. What is your overall rating of the Scientific Session?


CFAR

N = 118

Evaluations (continued)Evaluations (continued)

E + G = 90.0 %


CFAR

Preliminary OutcomesPreliminary Outcomes

● Cross-CFAR analysis of mentoring strategies– James Kahn, UCSF

● Minority investigator recruitment/mentoring initiative – Michael Marmor, NYU

● Identified 2 sources to develop and host SBSRN collaborative website (UAB, UW)

● Identified tentative host sites for annual SBSRN conference (UAB 2007, UW 2008, Brown/Harvard collaboration 2009)

● Cross-CFAR analysis of mentoring strategies– James Kahn, UCSF

● Minority investigator recruitment/mentoring initiative – Michael Marmor, NYU

● Identified 2 sources to develop and host SBSRN collaborative website (UAB, UW)

● Identified tentative host sites for annual SBSRN conference (UAB 2007, UW 2008, Brown/Harvard collaboration 2009)

Proposed Action PlanProposed Action Plan

● JAIDS Journal Supplement (August 2007)

● R13 Conference grant

● SBSRN Listserv

● SBSRN website/web-based directory

● JAIDS Journal Supplement (August 2007)

● R13 Conference grant

● SBSRN Listserv

● SBSRN website/web-based directory


CFAR


CFAR

Proposed JAIDS SupplementSocial and Behavioral Sciences Research Network: “Research Lessons: Setting the Social

and Behavioral Sciences Agenda for Future HIV/AIDS Research”

Introduction - Metzger, Blank, Wingood, DiClemente

● NIH Perspectives on Social & Behavioral Science Research in the Context of CFAR - Gordon, Young, Newcomer, et al.

● Guest Editorial - Hoxie, Curran

● Mentoring the Next Generation of CFAR HIV Investigators - Kahn

● Global Perspective of the HIV Pandemic - Beyrer, et al.

● Cost Effectiveness Trials in HIV Prevention Studies - Pinkerton, et al.

● Factors Impacting on HIV Prevention and Treatment Effectiveness

(Mental Health and Substance Abuse) - Walkup, et al.

Proposed JAIDS SupplementSocial and Behavioral Sciences Research Network: “Research Lessons: Setting the Social

and Behavioral Sciences Agenda for Future HIV/AIDS Research”

Introduction - Metzger, Blank, Wingood, DiClemente

● NIH Perspectives on Social & Behavioral Science Research in the Context of CFAR - Gordon, Young, Newcomer, et al.

● Guest Editorial - Hoxie, Curran

● Mentoring the Next Generation of CFAR HIV Investigators - Kahn

● Global Perspective of the HIV Pandemic - Beyrer, et al.

● Cost Effectiveness Trials in HIV Prevention Studies - Pinkerton, et al.

● Factors Impacting on HIV Prevention and Treatment Effectiveness

(Mental Health and Substance Abuse) - Walkup, et al.


CFAR

● Examining and Reducing HIV Disparities in Race, Class, Gender and AgeAral, et al.

● Looking Toward the Future: Strategies to Identify and Intervene with Persons at Greatest Risk of HIV Infections (Prevention with Vulnerable Populations)Coates, et al.

● Defining, Designing, Implementing, and Evaluating Effectiveness Trials for Vulnerable Populations (Translational Research and Effectiveness Trials)Spielberg, Kelly, et al.

● HIV/AIDS Foundations - Goosby, et al.

● Community Involvement in HIV Research - Wakefield, Grundy, et al.

● Recruitment and Training of Minority Investigators - Marmor, et al.

● Adapting Evidence-based HIV Prevention Programs for Diverse Populations - Wingood, DiClemente

● Conclusions & Acknowledgements - DiClemente, Wingood, Metzger, Blank

● Examining and Reducing HIV Disparities in Race, Class, Gender and AgeAral, et al.

● Looking Toward the Future: Strategies to Identify and Intervene with Persons at Greatest Risk of HIV Infections (Prevention with Vulnerable Populations)Coates, et al.

● Defining, Designing, Implementing, and Evaluating Effectiveness Trials for Vulnerable Populations (Translational Research and Effectiveness Trials)Spielberg, Kelly, et al.

● HIV/AIDS Foundations - Goosby, et al.

● Community Involvement in HIV Research - Wakefield, Grundy, et al.

● Recruitment and Training of Minority Investigators - Marmor, et al.

● Adapting Evidence-based HIV Prevention Programs for Diverse Populations - Wingood, DiClemente

● Conclusions & Acknowledgements - DiClemente, Wingood, Metzger, Blank

What participants liked most about the Scientific SessionWhat participants liked most about the Scientific Session

● Cost effectiveness is a new topic for behavioral science meeting

● Linking this to the need for research in less than ideal conditions

● The development of issues about disparities that went beyond blaming the person or the society.

● Stimulated new ways of organizing how to think about inputs into disparity; excellent, stimulating session

● Cost effectiveness is a new topic for behavioral science meeting

● Linking this to the need for research in less than ideal conditions

● The development of issues about disparities that went beyond blaming the person or the society.

● Stimulated new ways of organizing how to think about inputs into disparity; excellent, stimulating session


CFAR

● Stimulating thought, discussion, protocol/trial development

● Brought out the importance and current lack of effectiveness trials

● Attention to structural factors at the same time the speaker attended to individual factors. Very complex understanding, which is necessary

● Excellent session. Very thoughtful presentation implemented by new data linking HIV genetic diversity and demographic/ epidemiologic-based statistics

● Stimulating thought, discussion, protocol/trial development

● Brought out the importance and current lack of effectiveness trials

● Attention to structural factors at the same time the speaker attended to individual factors. Very complex understanding, which is necessary

● Excellent session. Very thoughtful presentation implemented by new data linking HIV genetic diversity and demographic/ epidemiologic-based statistics

What Participants Liked Most about the Scientific SessionWhat Participants Liked Most about the Scientific Session

What Participants Liked Most about the Scientific SessionWhat Participants Liked Most about the Scientific Session

● Thoughtful review of the issues and provided some new insights on the topic

● Stimulated a lot of thinking

● Clear, up to date, included critical assessments of the state of the field

● Forcing me to rethink ideas that I thought I had already resolved in my mind.

● Thoughtful review of the issues and provided some new insights on the topic

● Stimulated a lot of thinking

● Clear, up to date, included critical assessments of the state of the field

● Forcing me to rethink ideas that I thought I had already resolved in my mind.


CFAR

AcknowledgementsAcknowledgements

● NIH Representatives

● Scientific Speakers

● SBSRN Planning Committee

● All participants

● NIH Representatives

● Scientific Speakers

● SBSRN Planning Committee

● All participants


CFAR

Documents

CFAR Social and Behavioral Sciences Research Network (SBSRN) 1 st Scientific Meeting Summary Philadelphia, PA October 10 -13, 2006 SBSRN Executive Committee